iVIGA Tap Factory Supplier
Thèid na trì taighean-beaga sin a lorg teicneòlasan slàinte a dhearbhadh gu clionaigeach anns na SA, Israel agus Iapan
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. Tha a’ chompanaidh air sreath de thrì peutantan a chuir a-steach a’ còmhdach eileamaidean den sensor toileat meidigeach aca.
Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Roinn-Eòrpa, Iapan agus Sìona.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Is urrainn do theicneòlas OutSense stòr fala a chomharrachadh air an t-slighe gastrointestinal.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.
A rèir Ceannard OutSense Yfat Scialom, who predicts that “leis an spreadhadh de leigheas didseatach, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, galaran caolan sèid agus galairean slighe urinary.
Its solution consists of a multispectral optical sensor, stòr solais agus inneal sgrìonaidh fèin-riaghailteach anns a bheil ceangal WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. Fiosrachadh air fhaighinn bho fhuil air a samplachadh, còmhla ri mion-sgrùdadh a bharrachd air an ùine bho bleeding gu excretion, a’ toirt seachad mion-fhiosrachadh air pathology bleeding. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, Dh’ ainmich OutSense gun robh CommuniCare, companaidh cùram slàinte mòr le barrachd air 90 healthcare facilities in the US, tòisichidh e air pìleat a theicneòlas am-bliadhna. A bharrachd air a’ phìleat seo, OutSense also plans to conduct clinical trials in Israel and Japan.
Visit More News at Viga.cc News